Baxter Healthcare Corporation vs RARE THYROID THERAPEUTICS INTERNATIONAL AB: FDA Enforcement Comparison

Baxter Healthcare Corporation has been the subject of 235 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for RARE THYROID THERAPEUTICS INTERNATIONAL AB.

Baxter Healthcare Corporation: 0 warning letters, 235 recalls, 0 approval records, 0 Form 483s.

RARE THYROID THERAPEUTICS INTERNATIONAL AB: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Side by side

Baxter Healthcare Corporation — Warning letters0

RARE THYROID THERAPEUTICS INTERNATIONAL AB — Warning letters0

Baxter Healthcare Corporation — Recalls235

RARE THYROID THERAPEUTICS INTERNATIONAL AB — Recalls0

Baxter Healthcare Corporation — Approval records0

RARE THYROID THERAPEUTICS INTERNATIONAL AB — Approval records1

Baxter Healthcare Corporation — Form 483s0

RARE THYROID THERAPEUTICS INTERNATIONAL AB — Form 483s0

Timeline

Baxter Healthcare Corporation

Most recent FDA action: September 30, 2026

Full history →

RARE THYROID THERAPEUTICS INTERNATIONAL AB

Most recent FDA action: September 28, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Baxter Healthcare Corporation vs RARE THYROID THERAPEUTICS INTERNATIONAL AB: FDA Enforcement Comparison." Argus HQ, accessed October 12, 2026. https://argushq.ai/compare/baxter-healthcare-corporation-vs-rare-thyroid-therapeutics-international-ab

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗